메뉴 건너뛰기




Volumn 42, Issue 8, 2014, Pages 1931-1932

The golden hour of antibiotic administration in severe sepsis: Avoid a false start striving for gold

Author keywords

antibiotics; appropriateness; mortality; sepsis; timing

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT;

EID: 84904675580     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0000000000000363     Document Type: Editorial
Times cited : (23)

References (12)
  • 1
    • 84883076264 scopus 로고    scopus 로고
    • Severe sepsis and septic shock
    • Angus DC, van der Poll T: Severe sepsis and septic shock. N Engl J Med 2013; 369:840-851
    • (2013) N Engl J Med , vol.369 , pp. 840-851
    • Angus, D.C.1    Van Der Poll, T.2
  • 2
    • 0036229241 scopus 로고    scopus 로고
    • Pharmacological principles of antibiotic prescription in the critically ill
    • Pinder M, Bellomo R, Lipman J: Pharmacological principles of antibiotic prescription in the critically ill. Anaesth Intensive Care 2002; 30:134-144
    • (2002) Anaesth Intensive Care , vol.30 , pp. 134-144
    • Pinder, M.1    Bellomo, R.2    Lipman, J.3
  • 3
    • 84873339299 scopus 로고    scopus 로고
    • Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock: 2012
    • Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup
    • Dellinger RP, Levy MM, Rhodes A, et al; Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup: Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013; 41:580-637
    • (2013) Crit Care Med , vol.41 , pp. 580-637
    • Dellinger, R.P.1    Levy, M.M.2    Rhodes, A.3
  • 4
    • 78049233262 scopus 로고    scopus 로고
    • Systematic review and meta-analysis of the effcacy of appropriate empiric antibiotic therapy for sepsis
    • Paul M, Shani V, Muchtar E, et al: Systematic review and meta-analysis of the effcacy of appropriate empiric antibiotic therapy for sepsis. Antimicrob Agents Chemother 2010; 54:4851-4863
    • (2010) Antimicrob Agents Chemother , vol.54 , pp. 4851-4863
    • Paul, M.1    Shani, V.2    Muchtar, E.3
  • 5
    • 33744527833 scopus 로고    scopus 로고
    • Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock
    • Kumar A, Roberts D, Wood KE, et al: Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006; 34:1589-1596
    • (2006) Crit Care Med , vol.34 , pp. 1589-1596
    • Kumar, A.1    Roberts, D.2    Wood, K.E.3
  • 6
    • 84904734154 scopus 로고    scopus 로고
    • Empiric Antibiotic Treatment Reduces Mortality in Severe Sepsis and Septic Shock from the First Hour: Results from a Guideline-Based Performance Improvement Program
    • Ferrer R, Martin-Loeches I, Phillips G, et al: Empiric Antibiotic Treatment Reduces Mortality in Severe Sepsis and Septic Shock From the First Hour: Results From a Guideline-Based Performance Improvement Program. Crit Care Med 2014; 42:1749-1755
    • (2014) Crit Care Med , vol.42 , pp. 1749-1755
    • Ferrer, R.1    Martin-Loeches, I.2    Phillips, G.3
  • 7
    • 83655172780 scopus 로고    scopus 로고
    • Effective antibiotic treatment prescribed by emergency physicians in patients admitted to the intensive care unit with severe sepsis or septic shock: Where is the gap?
    • Capp R, Chang Y, Brown DF: Effective antibiotic treatment prescribed by emergency physicians in patients admitted to the intensive care unit with severe sepsis or septic shock: Where is the gap? J Emerg Med 2011; 41:573-580
    • (2011) J Emerg Med , vol.41 , pp. 573-580
    • Capp, R.1    Chang, Y.2    Brown, D.F.3
  • 8
    • 49749094394 scopus 로고    scopus 로고
    • Ciprofoxacin pharmacokinetics in critically ill patients: A prospective cohort study
    • van Zanten AR, Polderman KH, van Geijlswijk IM, et al: Ciprofoxacin pharmacokinetics in critically ill patients: A prospective cohort study. J Crit Care 2008; 23:422-430
    • (2008) J Crit Care , vol.23 , pp. 422-430
    • Van Zanten, A.R.1    Polderman, K.H.2    Van Geijlswijk, I.M.3
  • 9
    • 0037389094 scopus 로고    scopus 로고
    • 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Defnitions Conference
    • SCCM/ESICM/ACCP/ATS/SIS
    • Levy MM, Fink MP, Marshall JC, et al; SCCM/ESICM/ACCP/ATS/SIS: 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Defnitions Conference. Crit Care Med 2003; 31:1250-1256
    • (2003) Crit Care Med , vol.31 , pp. 1250-1256
    • Levy, M.M.1    Fink, M.P.2    Marshall, J.C.3
  • 10
    • 84901493076 scopus 로고    scopus 로고
    • Access to antibiotics: A safety and equity challenge for the next decade
    • Carlet J, Pittet D: Access to antibiotics: A safety and equity challenge for the next decade. Antimicrob Resist Infect Control 2013; 2:1
    • (2013) Antimicrob Resist Infect Control , vol.2 , pp. 1
    • Carlet, J.1    Pittet, D.2
  • 11
    • 70349106772 scopus 로고    scopus 로고
    • The measurement of time to frst antibiotic dose for pneumonia in the emergency department: A white paper and position statement prepared for the American Academy of Emergency Medicine
    • Pines JM, Isserman JA, Hinfey PB: The measurement of time to frst antibiotic dose for pneumonia in the emergency department: A white paper and position statement prepared for the American Academy of Emergency Medicine. J Emerg Med 2009; 37:335-340
    • (2009) J Emerg Med , vol.37 , pp. 335-340
    • Pines, J.M.1    Isserman, J.A.2    Hinfey, P.B.3
  • 12
    • 84891026537 scopus 로고    scopus 로고
    • De-escalation of empirical therapy is associated with lower mortality in patients with severe sepsis and septic shock
    • Garnacho-Montero J, Gutiérrez-Pizarraya A, Escoresca-Ortega A, et al: De-escalation of empirical therapy is associated with lower mortality in patients with severe sepsis and septic shock. Intensive Care Med 2014; 40:32-40
    • (2014) Intensive Care Med , vol.40 , pp. 32-40
    • Garnacho-Montero, J.1    Gutiérrez-Pizarraya, A.2    Escoresca-Ortega, A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.